Venture Capital Firms
VC funds with an active thesis and recent deals in Biotech & Healthcare.
View service →Reach life sciences investors who understand clinical milestones, regulatory pathways and the long development timelines of biotech and medical innovation.
Biotech and healthcare companies raise capital against scientific and clinical milestones rather than revenue. Investors in this space are highly specialised by therapeutic area, modality and development stage, and many have scientific or medical partners on their teams.
We research investors across therapeutics, medical devices, diagnostics, life science tools, healthcare services and pharma services, and record each investor's preferred stage, from preclinical through clinical trials and commercialisation.
Your list will focus on life sciences VCs, crossover funds, family offices with healthcare mandates, pharma corporate venture arms and strategic partners that can support both funding and development.
VC funds with an active thesis and recent deals in Biotech & Healthcare.
View service →Operator-angels and syndicates with Biotech & Healthcare experience.
View service →Single and multi-family offices with direct-investment mandates.
View service →Growth and buyout funds for later-stage Biotech & Healthcare companies.
View service →Corporate venture arms investing in Biotech & Healthcare innovation.
View service →Industry players who invest for synergy and distribution.
View service →We learn about your company, funding stage and investment requirements.
We identify investors aligned with your industry and criteria.
We research investor profiles, portfolios and relevant decision-makers.
We organize the research into a structured investor pipeline.
Generic investor lists waste time on funds that will never invest in Biotech & Healthcare. Industry-specific research helps you focus outreach on investors who already understand your market.
Find Biotech InvestorsFocus on investors who have already backed Biotech & Healthcare companies and understand your market.
Investors with domain knowledge ask better questions and add more value after the check.
Only approach investors who actively fund companies at your current stage.
Target investors who invest in your market and understand its dynamics.
Find complementary portfolios and avoid investors backing direct competitors.
We research life sciences VCs, crossover funds, family offices with healthcare mandates, angel networks, pharma and medtech corporate venture arms and strategic partners.
Yes. We filter investors by therapeutic focus such as oncology, neurology or rare disease, and by modality such as small molecules, biologics, cell and gene therapy or devices.
Yes. We note whether investors back preclinical, clinical-stage or commercial companies, so you approach investors who fund your current milestone.
Yes. We include pharma and medtech CVCs and business development teams where they are a fit for your programme.
Every list is built around your science, stage, therapeutic area, geography and raise size.
Tell us about your company, funding requirements, and target investor profile. We'll build research around your specific criteria.